Cambridge Cognition Holdings PLC (LON:COG)‘s stock had its “corporate” rating restated by investment analysts at FinnCap in a research report issued on Tuesday. They presently have a GBX 100 ($1.31) price objective on the stock. FinnCap’s target price points to a potential upside of 30.72% from the stock’s current price.

Cambridge Cognition Holdings PLC (LON:COG) opened at 72.00 on Tuesday. Cambridge Cognition Holdings PLC has a 52 week low of GBX 30.00 and a 52 week high of GBX 105.00. The firm has a 50-day moving average price of GBX 55.88 and a 200-day moving average price of GBX 44.98. The stock’s market cap is GBX 12.18 million.

About Cambridge Cognition Holdings PLC

Cambridge Cognition Holdings plc is a holding company. The Company operates through its wholly owned subsidiary, Cambridge Cognition Limited (CCL). It develops and commercializes computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company has three segments: Healthcare, which includes medical software for use in healthcare delivery settings; Academic Research, which includes cognitive test products for researchers working in a non-regulated environment, and Clinical Trials, which includes products and services for use in regulated pharmaceutical clinical trials.

Receive News & Ratings for Cambridge Cognition Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition Holdings PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.